• Title/Summary/Keyword: Salvia miltiorrhiza Radix

Search Result 22, Processing Time 0.015 seconds

Analysis of Sulfur Dioxide Residue in Commercial Medicine Prepared from Crude Drugs (생약제제 중 이산화황 잔류실태 시중 유통 생약제제 중 이산화황의 잔류실태 조사)

  • Lee, Chun-Yeong;Lee, Jeong-Sook;Lee, Hyun-Kyung;Park, Won-Hee;Kim, Jeong-Gon;Chung, Ae-Hee
    • YAKHAK HOEJI
    • /
    • v.56 no.1
    • /
    • pp.55-59
    • /
    • 2012
  • This study was carried out to investigate the content of sulfur dioxide residues in the medicine prepared from crue drugs. Total 29 pills that contains salvia miltiorrhiza root, anemarrhena rhizome, fritillaria bulb, glehnia root, asparagus tuber, lycium fruit, moutan root bark, cimicifuga rhizome, pinellia tuber, dipsaci radix, codonopsis pilosula root, liriope tuber, achyranthes root, prepared aconite, aurantii fructus immaturus, corydalis tuber, dioscorea rhizome were examined by the modified Monier_Willams method. Sulfur dioxide were detectd in all the tested samples, and were found over MRLs (30 mg/ kg to medicinal herbs) in 8 samples (27.6%). Especilly, "i2" pills contains 132.46 mg/kg sulfur dioxide that is 4 times over than MRLs.

Inhibitory Effects of Allergic Reaction of Aqueous Extract of Salviae Radix Root by Anal Therapy (항장요법(肛腸療法)에 의한 단삼추출액(丹蔘抽出液)의 알레르기반응 억제효과(抑制效果))

  • Cho, Jung-Youn;Moon, Seok-Jae;Moon, Goo;Won, Jin-Hee;Kim, Hyung-Min
    • The Journal of Korean Medicine
    • /
    • v.20 no.1 s.37
    • /
    • pp.11-21
    • /
    • 1999
  • Dansam, the root of Salvia miltiorrhiza BGE. (Labiatae), has a bitter and a slightly 'cold' property. and is nontoxic. It has been used for the treatment of diseases such as tumors, bruises, gynecologic diseases, menoxenia, anemia and so forth. As an oriental medicine pathway, anal therapy has many kinds of treatments, Retention enema is one the most useful, advantageous methods of anal therapy. This experiment was performed in order to study the effect of an aqueous extract of Salviae radix root(SRRAE) on Immediate type allergic reaction by Retention enema. The results were obtained as follows, 1. SRRAE inhibited compound 48/80-induced Immediate type allergic reaction 100% with the dose of 0.1g/kg by anal treatment. However, SRRAE showed no significant inhibitory effect on the same reaction by oral treatment. When mice were pretreated with SRRAE at a concentration ranging from 0.001 to 1.0g/kg, by intra-anal treatment, the serum histamine levels were reduced in a dose-dependent manner. 2. SRRAE also inhibited by 79.8% local cutaneous allergic reaction activated by anti-dinitrophenyl (DNP) IgE. 3. SRRAE close-dependently inhibited the histamine release from rat peritoneal mast cells(RPMC) by anti-DNP IgE., but SRRAE not inhibited compound 48/80-induced histamine release. 4. SRRAE dose-dependently inhibited tumor necrosis $factor-\;{\alpha}$ $(TNF-\;{\alpha}$) production from RPMC by anti-DNP IgE. Moreover, the level of cAMP in RPMC, when SRRAE was added, significantly increased compared with that of a normal control. According to the above results, anal therapy(Retention enema) of SRRAE may be beneficial in the treatment of systemic and local Immediate type allergic reactions.

  • PDF